Cargando…
Reliability and Reproducibility of Absolute Myocardial Blood Flow: Does It Depend on the PET/CT Technology, the Vasodilator, and/or the Software?
PURPOSE OF REVIEW: The COURAGE and ISCHEMIA trials showed no reduced mortality after revascularization compared to medical treatment. Is this lack of benefit due to revascularization having no benefit regardless of CAD severity or to suboptimal patient selection due to non-quantitative cardiac imagi...
Autores principales: | Gould, K. Lance, Bui, Linh, Kitkungvan, Danai, Patel, Monica B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822783/ https://www.ncbi.nlm.nih.gov/pubmed/33483794 http://dx.doi.org/10.1007/s11886-021-01449-8 |
Ejemplares similares
-
How Do PET Myocardial Blood Flow Reserve and FFR Differ?
por: Johnson, Nils P., et al.
Publicado: (2020) -
Regulatory Agencies and PET/CT Imaging in the Clinic
por: Herscovitch, Peter
Publicado: (2022) -
Molecular Imaging Using Cardiac PET/CT: Opportunities to Harmonize Diagnosis and Therapy
por: Thackeray, James T.
Publicado: (2021) -
PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
por: Sivapackiam, Jothilingam, et al.
Publicado: (2020) -
PET Imaging of Post-infarct Myocardial Inflammation
por: Ćorović, Andrej, et al.
Publicado: (2021)